Resonant Link Medical has appointed veteran medical technology leader Raymond W. Cohen as Chair of its Board of Directors, supporting the company’s expansion and adoption of its Aurion WPT™ wireless technology platform across even more clinical use cases.
“One of the biggest drawbacks of many implantable medical devices today is their power and energy requirements,” said Cohen. “Limitations like frustrating, hours-long recharging or battery replacement surgeries when non-rechargeable batteries expire reduce patient adoption and compromise quality of life. These limitations are especially pronounced in devices encased in titanium. Resonant Link Medical’s technology, built on its proprietary concept of multi-layer self-resonant structure (MSRS), delivers hyper-efficient, MRI-compatible wireless charging at implant depths of up to six centimeters that improves patient adoption and quality of life.”
“Ray’s deep experience building and guiding category-defining medical technology companies makes him an invaluable addition to our board,” said Omari Bouknight, CEO of Resonant Link Medical. “His track record of scaling innovative companies will help us accelerate Resonant Link Medical’s mission to power life-changing therapies along with our medical device partners.”
Cohen has led multiple companies through commercialization, IPOs, and acquisitions, most recently guiding Axonics as CEO from its founding to a $3.7 billion sale to Boston Scientific Corporation. His appointment as Chair highlights Resonant Link Medical’s momentum as it grows its team, unveils new branding, and advances adoption of its Aurion WPT™ wireless power and data transfer across a wide range of implantable devices, from ventricular assist devices and brain-computer interfaces to tiny neurostimulators and diagnostic devices. To learn more, read the formal announcement or contact us.
Jim Hammerand, Managing Editor of Medical Design & Outsourcing, recently sat down with Cohen to discuss what he's learned after decades in the industry and why he's excited to step into his new role with Resonant Link Medical. Read Part 1 of his interview here and follow us to be notified when Part 2 comes out.
